Developmental changes in pharmacokinetics and pharmacodynamics of warfarin enantiomers in Japanese children View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

2000-11

AUTHORS

Harumi Takahashi, Shiro Ishikawa, Shinichi Nomoto, Yoshiyuki Nishigaki, Fumitaka Ando, Toshitaka Kashima, Sosuke Kimura, Madoka Kanamori, Hirotoshi Echizen

ABSTRACT

OBJECTIVE: To clarify developmental changes in the pharmacokinetics and dynamics of warfarin enantiomers to establish rational pediatric dosage. METHODS: Plasma concentrations of unbound warfarin enantiomers, vitamin K1 and vitamin K-dependent proteins (that is, prothrombin fragments 1+2, protein C, and the protein-induced by vitamin K absence) and international normalized ratio were measured in 38 prepubertal (1 to 11 years), 15 pubertal (12 to 18 years), and 81 adult (37 to 76 years) patients given long-term warfarin therapy. Unbound oral clearance values for warfarin enantiomers and its body weight-, body surface area-, and liver weight-normalized values, as well as the pharmacodynamic parameters, were compared among the groups. RESULTS: The prepubertal, pubertal, and adult patients exhibited comparable mean plasma concentrations of unbound warfarin enantiomers for pharmacologically more active (S)-warfarin. Although the unbound oral clearance of (S)-warfarin for the prepubertal patients was significantly (P < .01) less than that for the adult group (346 versus 637 mL/min), the body weight-normalized unbound oral clearance for the prepubertal patients was significantly (P < .01) greater than that for the adults and showed a negative correlation (P < .05) with age. In contrast, no differences were observed in the liver weight-normalized unbound oral clearance for (S)-warfarin between the prepubertal and adult groups. The prepubertal patients showed significantly (P < .01 or .05) lower plasma concentrations of protein C and prothrombin fragments 1+2 and greater international normalized ratio and international normalized ratio/dose than the adults. In contrast, the pubertal patients showed largely similar pharmacokinetic and pharmacodynamic properties to adults. CONCLUSION: Liver weight may be a better parameter than body weight for estimating the warfarin doses for prepubertal patients on the basis of the corresponding adult values. Augmented responses to warfarin in children should also be taken into account for estimating warfarin doses for children. More... »

PAGES

541-555

Identifiers

URI

http://scigraph.springernature.com/pub.10.1067/mcp.2000.110977

DOI

http://dx.doi.org/10.1067/mcp.2000.110977

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1037094769

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/11103757


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1103", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Clinical Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Adolescent", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Adult", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Aging", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Anticoagulants", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Aryl Hydrocarbon Hydroxylases", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Child", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Child, Preschool", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Cytochrome P-450 Enzyme System", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Female", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Half-Life", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Infant", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Japan", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Liver", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Male", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Metabolic Clearance Rate", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Middle Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Prothrombin", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Stereoisomerism", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Steroid 16-alpha-Hydroxylase", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Steroid Hydroxylases", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Vitamin K", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Warfarin", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Meiji Pharmaceutical University", 
          "id": "https://www.grid.ac/institutes/grid.411763.6", 
          "name": [
            "Meiji Pharmaceutical University Department of Pharmacotherapy Tokyo"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Takahashi", 
        "givenName": "Harumi", 
        "id": "sg:person.016673612404.16", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.016673612404.16"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "name": [
            "Department of Pediatric Cardiology, Fukuoka Children's Hospital Fukuoka"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Ishikawa", 
        "givenName": "Shiro", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "name": [
            "Department of Cardiovascular Surgery, Otsu Red Cross Hospital Kyoto"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Nomoto", 
        "givenName": "Shinichi", 
        "id": "sg:person.01007326500.30", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01007326500.30"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "name": [
            "Department of Cardiovascular Surgery, Hyogo Prefectural Amagasaki Hospital Hyogo"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Nishigaki", 
        "givenName": "Yoshiyuki", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "name": [
            "Department of Cardiovascular Surgery, Hyogo Prefectural Amagasaki Hospital Hyogo"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Ando", 
        "givenName": "Fumitaka", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "name": [
            "The Department of Cardiovascular Surgery, International Medical Center of Japan Tokyo"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Kashima", 
        "givenName": "Toshitaka", 
        "id": "sg:person.0775675414.59", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0775675414.59"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "name": [
            "The Department of Cardiovascular Surgery, International Medical Center of Japan Tokyo"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Kimura", 
        "givenName": "Sosuke", 
        "id": "sg:person.01143242567.65", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01143242567.65"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Meiji Pharmaceutical University", 
          "id": "https://www.grid.ac/institutes/grid.411763.6", 
          "name": [
            "Meiji Pharmaceutical University Department of Pharmacotherapy Tokyo"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Kanamori", 
        "givenName": "Madoka", 
        "id": "sg:person.01077773051.32", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01077773051.32"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Meiji Pharmaceutical University", 
          "id": "https://www.grid.ac/institutes/grid.411763.6", 
          "name": [
            "Meiji Pharmaceutical University Department of Pharmacotherapy Tokyo"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Echizen", 
        "givenName": "Hirotoshi", 
        "id": "sg:person.01201654463.93", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01201654463.93"
        ], 
        "type": "Person"
      }
    ], 
    "datePublished": "2000-11", 
    "datePublishedReg": "2000-11-01", 
    "description": "OBJECTIVE: To clarify developmental changes in the pharmacokinetics and dynamics of warfarin enantiomers to establish rational pediatric dosage.\nMETHODS: Plasma concentrations of unbound warfarin enantiomers, vitamin K1 and vitamin K-dependent proteins (that is, prothrombin fragments 1+2, protein C, and the protein-induced by vitamin K absence) and international normalized ratio were measured in 38 prepubertal (1 to 11 years), 15 pubertal (12 to 18 years), and 81 adult (37 to 76 years) patients given long-term warfarin therapy. Unbound oral clearance values for warfarin enantiomers and its body weight-, body surface area-, and liver weight-normalized values, as well as the pharmacodynamic parameters, were compared among the groups.\nRESULTS: The prepubertal, pubertal, and adult patients exhibited comparable mean plasma concentrations of unbound warfarin enantiomers for pharmacologically more active (S)-warfarin. Although the unbound oral clearance of (S)-warfarin for the prepubertal patients was significantly (P < .01) less than that for the adult group (346 versus 637 mL/min), the body weight-normalized unbound oral clearance for the prepubertal patients was significantly (P < .01) greater than that for the adults and showed a negative correlation (P < .05) with age. In contrast, no differences were observed in the liver weight-normalized unbound oral clearance for (S)-warfarin between the prepubertal and adult groups. The prepubertal patients showed significantly (P < .01 or .05) lower plasma concentrations of protein C and prothrombin fragments 1+2 and greater international normalized ratio and international normalized ratio/dose than the adults. In contrast, the pubertal patients showed largely similar pharmacokinetic and pharmacodynamic properties to adults.\nCONCLUSION: Liver weight may be a better parameter than body weight for estimating the warfarin doses for prepubertal patients on the basis of the corresponding adult values. Augmented responses to warfarin in children should also be taken into account for estimating warfarin doses for children.", 
    "genre": "research_article", 
    "id": "sg:pub.10.1067/mcp.2000.110977", 
    "inLanguage": [
      "en"
    ], 
    "isAccessibleForFree": false, 
    "isPartOf": [
      {
        "id": "sg:journal.1017409", 
        "issn": [
          "0009-9236", 
          "1532-6535"
        ], 
        "name": "Clinical Pharmacology & Therapeutics", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "5", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "68"
      }
    ], 
    "name": "Developmental changes in pharmacokinetics and pharmacodynamics of warfarin enantiomers in Japanese children", 
    "pagination": "541-555", 
    "productId": [
      {
        "name": "readcube_id", 
        "type": "PropertyValue", 
        "value": [
          "b0b4d0e02b6c983d5e8f9e62af1f8ac6d424f51390ff30531deefa7689d5acf2"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "11103757"
        ]
      }, 
      {
        "name": "nlm_unique_id", 
        "type": "PropertyValue", 
        "value": [
          "0372741"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1067/mcp.2000.110977"
        ]
      }, 
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1037094769"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1067/mcp.2000.110977", 
      "https://app.dimensions.ai/details/publication/pub.1037094769"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2019-04-10T18:36", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-uberresearch-data-dimensions-target-20181106-alternative/cleanup/v134/2549eaecd7973599484d7c17b260dba0a4ecb94b/merge/v9/a6c9fde33151104705d4d7ff012ea9563521a3ce/jats-lookup/v90/0000000001_0000000264/records_8678_00000063.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "http://onlinelibrary.wiley.com/doi/10.1067/mcp.2000.110977/abstract"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1067/mcp.2000.110977'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1067/mcp.2000.110977'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1067/mcp.2000.110977'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1067/mcp.2000.110977'


 

This table displays all metadata directly associated to this object as RDF triples.

230 TRIPLES      20 PREDICATES      53 URIs      45 LITERALS      33 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1067/mcp.2000.110977 schema:about N0457f88354b942c8b131ca05d0a3d3ff
2 N193e13d90b02485c82c61aa85a2806c1
3 N3b9f27bf2eb1474e8de9a3160781c5ae
4 N3e5a605fb4db461da731e408aa1ea4a0
5 N3f76f6d7d74d4a4bb5a8f492f8ed4304
6 N4924fc8ff231413d99efcf61ffd952e6
7 N67fc7660a0b244dea6ca2a9a3e558109
8 N7ceedbd920b14e239c33aff813ee260b
9 N800eb42503604c2bad4f89a8d844199b
10 N812c5c31c76940ca9c5805c8ad33863a
11 N98a8452f8fef41fd83658df896cc850b
12 N9ed050ebad164802844854eaad64c838
13 Na4fe2fd29b6e461d9caea15f3e070f29
14 Nbb779922cc644741ab015de9bd2e8b5e
15 Nc4961732ca35446b8a1a3e3bee64d42e
16 Nc5679f104f904b33a6e009cb9711411e
17 Nc98344b57298438f9e21327fe0e63b83
18 Nd6cfab7836434feaaf4b33b42c9d1b96
19 Ndb927aa2b7a7482a91049b0d5075ee8a
20 Nde90c0d28fbe4d57a16a6869a5341544
21 Ne76032e491484188970fb4003ab49625
22 Neea2bfbbd09148b1817d7f67e6786689
23 Nf4bff44cd26c48f4a0e0ec4b6fa8635b
24 Nf7706e65b9ae450e9f832612a3f939a4
25 anzsrc-for:11
26 anzsrc-for:1103
27 schema:author N29d8d53ac60844c1a227000ad379b69c
28 schema:datePublished 2000-11
29 schema:datePublishedReg 2000-11-01
30 schema:description OBJECTIVE: To clarify developmental changes in the pharmacokinetics and dynamics of warfarin enantiomers to establish rational pediatric dosage. METHODS: Plasma concentrations of unbound warfarin enantiomers, vitamin K1 and vitamin K-dependent proteins (that is, prothrombin fragments 1+2, protein C, and the protein-induced by vitamin K absence) and international normalized ratio were measured in 38 prepubertal (1 to 11 years), 15 pubertal (12 to 18 years), and 81 adult (37 to 76 years) patients given long-term warfarin therapy. Unbound oral clearance values for warfarin enantiomers and its body weight-, body surface area-, and liver weight-normalized values, as well as the pharmacodynamic parameters, were compared among the groups. RESULTS: The prepubertal, pubertal, and adult patients exhibited comparable mean plasma concentrations of unbound warfarin enantiomers for pharmacologically more active (S)-warfarin. Although the unbound oral clearance of (S)-warfarin for the prepubertal patients was significantly (P < .01) less than that for the adult group (346 versus 637 mL/min), the body weight-normalized unbound oral clearance for the prepubertal patients was significantly (P < .01) greater than that for the adults and showed a negative correlation (P < .05) with age. In contrast, no differences were observed in the liver weight-normalized unbound oral clearance for (S)-warfarin between the prepubertal and adult groups. The prepubertal patients showed significantly (P < .01 or .05) lower plasma concentrations of protein C and prothrombin fragments 1+2 and greater international normalized ratio and international normalized ratio/dose than the adults. In contrast, the pubertal patients showed largely similar pharmacokinetic and pharmacodynamic properties to adults. CONCLUSION: Liver weight may be a better parameter than body weight for estimating the warfarin doses for prepubertal patients on the basis of the corresponding adult values. Augmented responses to warfarin in children should also be taken into account for estimating warfarin doses for children.
31 schema:genre research_article
32 schema:inLanguage en
33 schema:isAccessibleForFree false
34 schema:isPartOf N99d13ae9e1ee46999dfc63ac45c3c2b5
35 Nfbb03f52828a4dc68330043ebb0fe1bc
36 sg:journal.1017409
37 schema:name Developmental changes in pharmacokinetics and pharmacodynamics of warfarin enantiomers in Japanese children
38 schema:pagination 541-555
39 schema:productId N0f0950f43fb142c98ac5145ba978ff00
40 N17f48e0b133249709208626cf40e9733
41 N553eadab035146369302574ab297e85d
42 Na263378c2b6a4b6682f16a030ebc2337
43 Nd71a24aef2994999a10d25908e8db7c9
44 schema:sameAs https://app.dimensions.ai/details/publication/pub.1037094769
45 https://doi.org/10.1067/mcp.2000.110977
46 schema:sdDatePublished 2019-04-10T18:36
47 schema:sdLicense https://scigraph.springernature.com/explorer/license/
48 schema:sdPublisher N553d2a1041524e2bb0dbbe25f9c93a6f
49 schema:url http://onlinelibrary.wiley.com/doi/10.1067/mcp.2000.110977/abstract
50 sgo:license sg:explorer/license/
51 sgo:sdDataset articles
52 rdf:type schema:ScholarlyArticle
53 N0457f88354b942c8b131ca05d0a3d3ff schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
54 schema:name Aging
55 rdf:type schema:DefinedTerm
56 N0f0950f43fb142c98ac5145ba978ff00 schema:name doi
57 schema:value 10.1067/mcp.2000.110977
58 rdf:type schema:PropertyValue
59 N0f165c6bc7284752812b21e029353d03 rdf:first N3ad13d0391f24669b37fe2cff301119b
60 rdf:rest N77b561d51db74605b1b1ef7335c53b4e
61 N17f48e0b133249709208626cf40e9733 schema:name readcube_id
62 schema:value b0b4d0e02b6c983d5e8f9e62af1f8ac6d424f51390ff30531deefa7689d5acf2
63 rdf:type schema:PropertyValue
64 N193e13d90b02485c82c61aa85a2806c1 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
65 schema:name Cytochrome P-450 Enzyme System
66 rdf:type schema:DefinedTerm
67 N22cdbb5a9e1f45d6b17fd7f5438c72d0 rdf:first Ne5f7e78bf70c48fe890eaa8c8523b01d
68 rdf:rest N3c5aa9e0bb894d9e83d06aa46d209176
69 N284a7f44b3c4478aa7ab21fa419f155f schema:name The Department of Cardiovascular Surgery, International Medical Center of Japan Tokyo
70 rdf:type schema:Organization
71 N29d8d53ac60844c1a227000ad379b69c rdf:first sg:person.016673612404.16
72 rdf:rest N22cdbb5a9e1f45d6b17fd7f5438c72d0
73 N32483fd733bc497d9df324e1f21cef87 rdf:first sg:person.0775675414.59
74 rdf:rest Na38275e613b24cd49f63df6fc7a9552a
75 N3ad13d0391f24669b37fe2cff301119b schema:affiliation N7df32f1bfbe745a899c4b039880dabc4
76 schema:familyName Nishigaki
77 schema:givenName Yoshiyuki
78 rdf:type schema:Person
79 N3b9f27bf2eb1474e8de9a3160781c5ae schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
80 schema:name Vitamin K
81 rdf:type schema:DefinedTerm
82 N3c5aa9e0bb894d9e83d06aa46d209176 rdf:first sg:person.01007326500.30
83 rdf:rest N0f165c6bc7284752812b21e029353d03
84 N3e5a605fb4db461da731e408aa1ea4a0 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
85 schema:name Male
86 rdf:type schema:DefinedTerm
87 N3f76f6d7d74d4a4bb5a8f492f8ed4304 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
88 schema:name Liver
89 rdf:type schema:DefinedTerm
90 N4924fc8ff231413d99efcf61ffd952e6 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
91 schema:name Aged
92 rdf:type schema:DefinedTerm
93 N4e80d6dfa44e44dba6d8d9da39a6dc8a schema:name Department of Pediatric Cardiology, Fukuoka Children's Hospital Fukuoka
94 rdf:type schema:Organization
95 N553d2a1041524e2bb0dbbe25f9c93a6f schema:name Springer Nature - SN SciGraph project
96 rdf:type schema:Organization
97 N553eadab035146369302574ab297e85d schema:name pubmed_id
98 schema:value 11103757
99 rdf:type schema:PropertyValue
100 N5828dc51bcb546d885a454ad760997ff schema:name Department of Cardiovascular Surgery, Hyogo Prefectural Amagasaki Hospital Hyogo
101 rdf:type schema:Organization
102 N5eb7f124ee51413e993a0eb0592ac3f6 rdf:first sg:person.01077773051.32
103 rdf:rest Na70f93949879401d8551255c7dbcb8c1
104 N67fc7660a0b244dea6ca2a9a3e558109 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
105 schema:name Steroid Hydroxylases
106 rdf:type schema:DefinedTerm
107 N75e8e667a87348e5925168ee5b718b8d schema:affiliation N5828dc51bcb546d885a454ad760997ff
108 schema:familyName Ando
109 schema:givenName Fumitaka
110 rdf:type schema:Person
111 N77b561d51db74605b1b1ef7335c53b4e rdf:first N75e8e667a87348e5925168ee5b718b8d
112 rdf:rest N32483fd733bc497d9df324e1f21cef87
113 N7ceedbd920b14e239c33aff813ee260b schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
114 schema:name Half-Life
115 rdf:type schema:DefinedTerm
116 N7df32f1bfbe745a899c4b039880dabc4 schema:name Department of Cardiovascular Surgery, Hyogo Prefectural Amagasaki Hospital Hyogo
117 rdf:type schema:Organization
118 N800eb42503604c2bad4f89a8d844199b schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
119 schema:name Child
120 rdf:type schema:DefinedTerm
121 N812c5c31c76940ca9c5805c8ad33863a schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
122 schema:name Stereoisomerism
123 rdf:type schema:DefinedTerm
124 N98a8452f8fef41fd83658df896cc850b schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
125 schema:name Warfarin
126 rdf:type schema:DefinedTerm
127 N99d13ae9e1ee46999dfc63ac45c3c2b5 schema:volumeNumber 68
128 rdf:type schema:PublicationVolume
129 N9ed050ebad164802844854eaad64c838 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
130 schema:name Japan
131 rdf:type schema:DefinedTerm
132 Na263378c2b6a4b6682f16a030ebc2337 schema:name nlm_unique_id
133 schema:value 0372741
134 rdf:type schema:PropertyValue
135 Na38275e613b24cd49f63df6fc7a9552a rdf:first sg:person.01143242567.65
136 rdf:rest N5eb7f124ee51413e993a0eb0592ac3f6
137 Na4fe2fd29b6e461d9caea15f3e070f29 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
138 schema:name Middle Aged
139 rdf:type schema:DefinedTerm
140 Na70f93949879401d8551255c7dbcb8c1 rdf:first sg:person.01201654463.93
141 rdf:rest rdf:nil
142 Na789f916d2274f45908489473eb77576 schema:name The Department of Cardiovascular Surgery, International Medical Center of Japan Tokyo
143 rdf:type schema:Organization
144 Nbb385d0c690d49da8961d5648d646db5 schema:name Department of Cardiovascular Surgery, Otsu Red Cross Hospital Kyoto
145 rdf:type schema:Organization
146 Nbb779922cc644741ab015de9bd2e8b5e schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
147 schema:name Adolescent
148 rdf:type schema:DefinedTerm
149 Nc4961732ca35446b8a1a3e3bee64d42e schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
150 schema:name Metabolic Clearance Rate
151 rdf:type schema:DefinedTerm
152 Nc5679f104f904b33a6e009cb9711411e schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
153 schema:name Humans
154 rdf:type schema:DefinedTerm
155 Nc98344b57298438f9e21327fe0e63b83 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
156 schema:name Adult
157 rdf:type schema:DefinedTerm
158 Nd6cfab7836434feaaf4b33b42c9d1b96 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
159 schema:name Female
160 rdf:type schema:DefinedTerm
161 Nd71a24aef2994999a10d25908e8db7c9 schema:name dimensions_id
162 schema:value pub.1037094769
163 rdf:type schema:PropertyValue
164 Ndb927aa2b7a7482a91049b0d5075ee8a schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
165 schema:name Aryl Hydrocarbon Hydroxylases
166 rdf:type schema:DefinedTerm
167 Nde90c0d28fbe4d57a16a6869a5341544 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
168 schema:name Infant
169 rdf:type schema:DefinedTerm
170 Ne5f7e78bf70c48fe890eaa8c8523b01d schema:affiliation N4e80d6dfa44e44dba6d8d9da39a6dc8a
171 schema:familyName Ishikawa
172 schema:givenName Shiro
173 rdf:type schema:Person
174 Ne76032e491484188970fb4003ab49625 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
175 schema:name Anticoagulants
176 rdf:type schema:DefinedTerm
177 Neea2bfbbd09148b1817d7f67e6786689 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
178 schema:name Child, Preschool
179 rdf:type schema:DefinedTerm
180 Nf4bff44cd26c48f4a0e0ec4b6fa8635b schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
181 schema:name Steroid 16-alpha-Hydroxylase
182 rdf:type schema:DefinedTerm
183 Nf7706e65b9ae450e9f832612a3f939a4 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
184 schema:name Prothrombin
185 rdf:type schema:DefinedTerm
186 Nfbb03f52828a4dc68330043ebb0fe1bc schema:issueNumber 5
187 rdf:type schema:PublicationIssue
188 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
189 schema:name Medical and Health Sciences
190 rdf:type schema:DefinedTerm
191 anzsrc-for:1103 schema:inDefinedTermSet anzsrc-for:
192 schema:name Clinical Sciences
193 rdf:type schema:DefinedTerm
194 sg:journal.1017409 schema:issn 0009-9236
195 1532-6535
196 schema:name Clinical Pharmacology & Therapeutics
197 rdf:type schema:Periodical
198 sg:person.01007326500.30 schema:affiliation Nbb385d0c690d49da8961d5648d646db5
199 schema:familyName Nomoto
200 schema:givenName Shinichi
201 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01007326500.30
202 rdf:type schema:Person
203 sg:person.01077773051.32 schema:affiliation https://www.grid.ac/institutes/grid.411763.6
204 schema:familyName Kanamori
205 schema:givenName Madoka
206 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01077773051.32
207 rdf:type schema:Person
208 sg:person.01143242567.65 schema:affiliation N284a7f44b3c4478aa7ab21fa419f155f
209 schema:familyName Kimura
210 schema:givenName Sosuke
211 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01143242567.65
212 rdf:type schema:Person
213 sg:person.01201654463.93 schema:affiliation https://www.grid.ac/institutes/grid.411763.6
214 schema:familyName Echizen
215 schema:givenName Hirotoshi
216 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01201654463.93
217 rdf:type schema:Person
218 sg:person.016673612404.16 schema:affiliation https://www.grid.ac/institutes/grid.411763.6
219 schema:familyName Takahashi
220 schema:givenName Harumi
221 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.016673612404.16
222 rdf:type schema:Person
223 sg:person.0775675414.59 schema:affiliation Na789f916d2274f45908489473eb77576
224 schema:familyName Kashima
225 schema:givenName Toshitaka
226 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0775675414.59
227 rdf:type schema:Person
228 https://www.grid.ac/institutes/grid.411763.6 schema:alternateName Meiji Pharmaceutical University
229 schema:name Meiji Pharmaceutical University Department of Pharmacotherapy Tokyo
230 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...